Splash Beverage Group Files Compliance Plan After NYSE Equity Shortfall Notice
On April 29, 2026, Splash Beverage Group received NYSE notice for failing to meet minimum shareholders’ equity and must file a compliance plan by May 29, 2026. The company secured a cure period until January 29, 2027 and delivered a draft merger agreement to Medterra CBD.
1. NYSE Equity Non-Compliance Notice
On April 29, 2026, Splash Beverage Group received a notice from NYSE American informing that its shareholders’ equity fell below the exchange’s minimum requirement. This non-compliance triggers a formal process and potential risk of delisting if not addressed.
2. Compliance Plan and Cure Timeline
The company must submit a detailed plan by May 29, 2026 outlining steps taken to restore equity levels, and if accepted, will have until January 29, 2027 to achieve compliance. Failure to meet these milestones could lead to suspension of trading.
3. Medterra Merger Discussions
Splash has delivered a draft letter of intent and proposed merger agreement to Medterra CBD, aiming to combine operations and strengthen its balance sheet. The merger remains subject to due diligence, definitive agreement, shareholder approval, and customary closing conditions.
4. Management Focus on Resilience
Board member Brady Cobb emphasized priorities of discipline, transparency, and building a resilient enterprise, stating the company is taking decisive steps to align with NYSE standards. Management is focused on balance sheet strengthening and regulatory compliance as part of long-term strategy.